<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-08-01" modified="2018-01-31" version="208">
<accession>P17612</accession>
<accession>Q32P54</accession>
<accession>Q9H2Y0</accession>
<accession>Q9NRB4</accession>
<accession>Q9NRH9</accession>
<name>KAPCA_HUMAN</name>
<protein>
<recommendedName>
<fullName>cAMP-dependent protein kinase catalytic subunit alpha</fullName>
<shortName>PKA C-alpha</shortName>
<ecNumber>2.7.11.11</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">PRKACA</name>
<name type="synonym">PKACA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Nucleic Acids Res." volume="16" first="8189" last="8190">
<title>A cDNA clone encoding human cAMP-dependent protein kinase catalytic subunit C alpha.</title>
<authorList>
<person name="Maldonado F."/>
<person name="Hanks S.K."/>
</authorList>
<dbReference type="PubMed" id="2843813"/>
<dbReference type="DOI" id="10.1093/nar/16.16.8189"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Thalamus</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2006-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Eye</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Biol. Reprod." volume="63" first="607" last="611">
<title>A novel isoform of human cyclic 3',5'-adenosine monophosphate-dependent protein kinase, c alpha-s, localizes to sperm midpiece.</title>
<authorList>
<person name="Reinton N."/>
<person name="Orstavik S."/>
<person name="Haugen T.B."/>
<person name="Jahnsen T."/>
<person name="Tasken K."/>
<person name="Skalhegg B.S."/>
</authorList>
<dbReference type="PubMed" id="10906071"/>
<dbReference type="DOI" id="10.1095/biolreprod63.2.607"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-189 (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Mol. Biol. Cell" volume="11" first="3031" last="3044">
<title>The unique catalytic subunit of sperm cAMP-dependent protein kinase is the product of an alternative C-alpha mRNA expressed specifically in spermatogenic cells.</title>
<authorList>
<person name="San Agustin J.T."/>
<person name="Wilkerson C.G."/>
<person name="Witman G.B."/>
</authorList>
<dbReference type="PubMed" id="10982398"/>
<dbReference type="DOI" id="10.1091/mbc.11.9.3031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-152 (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="6433" last="6438">
<title>Expression of a nonmyristylated variant of the catalytic subunit of protein kinase A during male germ-cell development.</title>
<authorList>
<person name="Desseyn J.-L."/>
<person name="Burton K.A."/>
<person name="McKnight G.S."/>
</authorList>
<dbReference type="PubMed" id="10841548"/>
<dbReference type="DOI" id="10.1073/pnas.97.12.6433"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-39 (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="47878" last="47884">
<title>Phosphorylation of the catalytic subunit of protein kinase A. Autophosphorylation versus phosphorylation by phosphoinositide-dependent kinase-1.</title>
<authorList>
<person name="Moore M.J."/>
<person name="Kanter J.R."/>
<person name="Jones K.C."/>
<person name="Taylor S.S."/>
</authorList>
<dbReference type="PubMed" id="12372837"/>
<dbReference type="DOI" id="10.1074/jbc.M204970200"/>
</citation>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT THR-196</scope>
<scope>PHOSPHORYLATION AT THR-198 BY PDK1</scope>
<scope>MUTAGENESIS OF ARG-195; GLY-201 AND THR-202</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="165" first="175" last="180">
<title>Rab13 regulates PKA signaling during tight junction assembly.</title>
<authorList>
<person name="Koehler K."/>
<person name="Louvard D."/>
<person name="Zahraoui A."/>
</authorList>
<dbReference type="PubMed" id="15096524"/>
<dbReference type="DOI" id="10.1083/jcb.200312118"/>
</citation>
<scope>INTERACTION WITH RAB13</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="9957" last="9962">
<title>DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit.</title>
<authorList>
<person name="Guan H."/>
<person name="Hou S."/>
<person name="Ricciardi R.P."/>
</authorList>
<dbReference type="PubMed" id="15642694"/>
<dbReference type="DOI" id="10.1074/jbc.M412180200"/>
</citation>
<scope>FUNCTION AS NFKB1 KINASE</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="26233" last="26240">
<title>Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells.</title>
<authorList>
<person name="D'Souza T."/>
<person name="Agarwal R."/>
<person name="Morin P.J."/>
</authorList>
<dbReference type="PubMed" id="15905176"/>
<dbReference type="DOI" id="10.1074/jbc.M502003200"/>
</citation>
<scope>FUNCTION AS CLDN3 KINASE</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="395" last="400">
<title>PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.</title>
<authorList>
<person name="Pasqualucci L."/>
<person name="Kitaura Y."/>
<person name="Gu H."/>
<person name="Dalla-Favera R."/>
</authorList>
<dbReference type="PubMed" id="16387847"/>
<dbReference type="DOI" id="10.1073/pnas.0509969103"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AICDA</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="22460" last="22471">
<title>Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6.</title>
<authorList>
<person name="Zhang F."/>
<person name="Hu Y."/>
<person name="Huang P."/>
<person name="Toleman C.A."/>
<person name="Paterson A.J."/>
<person name="Kudlow J.E."/>
</authorList>
<dbReference type="PubMed" id="17565987"/>
<dbReference type="DOI" id="10.1074/jbc.M702439200"/>
</citation>
<scope>FUNCTION IN PROTEASOME REGULATION</scope>
<scope>FUNCTION AS PSMC5/RPT6 KINASE</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="30256" last="30264">
<title>Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: sensitization of store overload-induced Ca2+ release.</title>
<authorList>
<person name="Xiao B."/>
<person name="Tian X."/>
<person name="Xie W."/>
<person name="Jones P.P."/>
<person name="Cai S."/>
<person name="Wang X."/>
<person name="Jiang D."/>
<person name="Kong H."/>
<person name="Zhang L."/>
<person name="Chen K."/>
<person name="Walsh M.P."/>
<person name="Cheng H."/>
<person name="Chen S.R.W."/>
</authorList>
<dbReference type="PubMed" id="17693412"/>
<dbReference type="DOI" id="10.1074/jbc.M703510200"/>
</citation>
<scope>FUNCTION AS RYR2 KINASE</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="J. Mol. Endocrinol." volume="39" first="239" last="247">
<title>Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells.</title>
<authorList>
<person name="Ichikawa T."/>
<person name="Horie-Inoue K."/>
<person name="Ikeda K."/>
<person name="Blumberg B."/>
<person name="Inoue S."/>
</authorList>
<dbReference type="PubMed" id="17909264"/>
<dbReference type="DOI" id="10.1677/JME-07-0048"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Breast Cancer Res. Treat." volume="107" first="63" last="70">
<title>Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cells.</title>
<authorList>
<person name="Xu H."/>
<person name="Washington S."/>
<person name="Verderame M.F."/>
<person name="Manni A."/>
</authorList>
<dbReference type="PubMed" id="17333334"/>
<dbReference type="DOI" id="10.1007/s10549-007-9536-5"/>
</citation>
<scope>FUNCTION AS ALPHA-DIFLUOROMETHYLORNITHINE ANTAGONIST</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49 AND SER-339</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Nat. Struct. Mol. Biol." volume="15" first="1184" last="1191">
<title>Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.</title>
<authorList>
<person name="Shirakawa K."/>
<person name="Takaori-Kondo A."/>
<person name="Yokoyama M."/>
<person name="Izumi T."/>
<person name="Matsui M."/>
<person name="Io K."/>
<person name="Sato T."/>
<person name="Sato H."/>
<person name="Uchiyama T."/>
</authorList>
<dbReference type="PubMed" id="18836454"/>
<dbReference type="DOI" id="10.1038/nsmb.1497"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH APOBEC3G</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="506" last="511">
<title>Allosteric cooperativity in protein kinase A.</title>
<authorList>
<person name="Masterson L.R."/>
<person name="Mascioni A."/>
<person name="Traaseth N.J."/>
<person name="Taylor S.S."/>
<person name="Veglia G."/>
</authorList>
<dbReference type="PubMed" id="18178622"/>
<dbReference type="DOI" id="10.1073/pnas.0709214104"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF TYR-205</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Exp. Cell Res." volume="315" first="1247" last="1259">
<title>Gravin dynamics regulates the subcellular distribution of PKA.</title>
<authorList>
<person name="Yan X."/>
<person name="Walkiewicz M."/>
<person name="Carlson J."/>
<person name="Leiphon L."/>
<person name="Grove B."/>
</authorList>
<dbReference type="PubMed" id="19210988"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2008.12.026"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="18352" last="18363">
<title>Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex.</title>
<authorList>
<person name="Gambaryan S."/>
<person name="Kobsar A."/>
<person name="Rukoyatkina N."/>
<person name="Herterich S."/>
<person name="Geiger J."/>
<person name="Smolenski A."/>
<person name="Lohmann S.M."/>
<person name="Walter U."/>
</authorList>
<dbReference type="PubMed" id="20356841"/>
<dbReference type="DOI" id="10.1074/jbc.M109.077602"/>
</citation>
<scope>FUNCTION IN PLATELETS</scope>
<scope>FUNCTION AS VASP KINASE</scope>
<scope>INTERACTION WITH NFKB1; NFKB2 AND NFKBIA</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Mol. Cell. Biochem." volume="338" first="115" last="122">
<title>High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway.</title>
<authorList>
<person name="Wang W."/>
<person name="Zhang X."/>
<person name="Zheng J."/>
<person name="Yang J."/>
</authorList>
<dbReference type="PubMed" id="19949837"/>
<dbReference type="DOI" id="10.1007/s11010-009-0344-6"/>
</citation>
<scope>FUNCTION IN OSTEOBLAST DIFFERENTIATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E13830" last="E13830">
<title>Protein kinase A binds and activates heat shock factor 1.</title>
<authorList>
<person name="Murshid A."/>
<person name="Chou S.D."/>
<person name="Prince T."/>
<person name="Zhang Y."/>
<person name="Bharti A."/>
<person name="Calderwood S.K."/>
</authorList>
<dbReference type="PubMed" id="21085490"/>
<dbReference type="DOI" id="10.1371/journal.pone.0013830"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HSF1</scope>
<scope>INTERACTION WITH HSF1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="408" first="442" last="446">
<title>Protein kinase A activates and phosphorylates ROR?4 in vitro and takes part in ROR? activation by CaMK-IV.</title>
<authorList>
<person name="Ermisch M."/>
<person name="Firla B."/>
<person name="Steinhilber D."/>
</authorList>
<dbReference type="PubMed" id="21514275"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2011.04.046"/>
</citation>
<scope>FUNCTION AS RORA KINASE</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="BMC Biochem." volume="12" first="40" last="40">
<title>The testis-specific C?2 subunit of PKA is kinetically indistinguishable from the common C?1 subunit of PKA.</title>
<authorList>
<person name="Vetter M.M."/>
<person name="Zenn H.-M."/>
<person name="Mendez E."/>
<person name="van den Boom H."/>
<person name="Herberg F.W."/>
<person name="Skaalhegg B.S."/>
</authorList>
<dbReference type="PubMed" id="21812984"/>
<dbReference type="DOI" id="10.1186/1471-2091-12-40"/>
</citation>
<scope>FUNCTION AS KINASE</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH PRKAR1A/PKR1 AND PRKAR2A/PKR2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Nat. Cell Biol." volume="13" first="412" last="422">
<title>Control of PKA stability and signalling by the RING ligase praja2.</title>
<authorList>
<person name="Lignitto L."/>
<person name="Carlucci A."/>
<person name="Sepe M."/>
<person name="Stefan E."/>
<person name="Cuomo O."/>
<person name="Nistico R."/>
<person name="Scorziello A."/>
<person name="Savoia C."/>
<person name="Garbi C."/>
<person name="Annunziato L."/>
<person name="Feliciello A."/>
</authorList>
<dbReference type="PubMed" id="21423175"/>
<dbReference type="DOI" id="10.1038/ncb2209"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="4919" last="4919">
<title>Global profiling of co- and post-translationally N-myristoylated proteomes in human cells.</title>
<authorList>
<person name="Thinon E."/>
<person name="Serwa R.A."/>
<person name="Broncel M."/>
<person name="Brannigan J.A."/>
<person name="Brassat U."/>
<person name="Wright M.H."/>
<person name="Heal W.P."/>
<person name="Wilkinson A.J."/>
<person name="Mann D.J."/>
<person name="Tate E.W."/>
</authorList>
<dbReference type="PubMed" id="25255805"/>
<dbReference type="DOI" id="10.1038/ncomms5919"/>
</citation>
<scope>MYRISTOYLATION AT GLY-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="Nat. Genet." volume="46" first="613" last="617">
<title>Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.</title>
<authorList>
<person name="Goh G."/>
<person name="Scholl U.I."/>
<person name="Healy J.M."/>
<person name="Choi M."/>
<person name="Prasad M.L."/>
<person name="Nelson-Williams C."/>
<person name="Kunstman J.W."/>
<person name="Kuntsman J.W."/>
<person name="Korah R."/>
<person name="Suttorp A.C."/>
<person name="Dietrich D."/>
<person name="Haase M."/>
<person name="Willenberg H.S."/>
<person name="Staalberg P."/>
<person name="Hellman P."/>
<person name="Akerstroem G."/>
<person name="Bjoerklund P."/>
<person name="Carling T."/>
<person name="Lifton R.P."/>
</authorList>
<dbReference type="PubMed" id="24747643"/>
<dbReference type="DOI" id="10.1038/ng.2956"/>
</citation>
<scope>INVOLVEMENT IN PPNAD4</scope>
<scope>VARIANT PPNAD4 ARG-206</scope>
<scope>CHARACTERIZATION OF VARIANT PPNAD4 ARG-206</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Angew. Chem. Int. Ed." volume="54" first="5948" last="5951">
<title>Multifunctional reagents for quantitative proteome-wide analysis of protein modification in human cells and dynamic profiling of protein lipidation during vertebrate development.</title>
<authorList>
<person name="Broncel M."/>
<person name="Serwa R.A."/>
<person name="Ciepla P."/>
<person name="Krause E."/>
<person name="Dallman M.J."/>
<person name="Magee A.I."/>
<person name="Tate E.W."/>
</authorList>
<dbReference type="PubMed" id="25807930"/>
<dbReference type="DOI" id="10.1002/anie.201500342"/>
</citation>
<scope>MYRISTOYLATION AT GLY-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Bioorg. Med. Chem. Lett." volume="16" first="4163" last="4168">
<title>Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.</title>
<authorList>
<person name="Lin X."/>
<person name="Murray J.M."/>
<person name="Rico A.C."/>
<person name="Wang M.X."/>
<person name="Chu D.T."/>
<person name="Zhou Y."/>
<person name="Del Rosario M."/>
<person name="Kaufman S."/>
<person name="Ma S."/>
<person name="Fang E."/>
<person name="Crawford K."/>
<person name="Jefferson A.B."/>
</authorList>
<dbReference type="PubMed" id="16765046"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2006.05.092"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 15-351</scope>
<scope>PHOSPHORYLATION AT THR-198 AND SER-339</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="1559" last="1564">
<title>Azole-based inhibitors of AKT/PKB for the treatment of cancer.</title>
<authorList>
<person name="Zeng Q."/>
<person name="Allen J.G."/>
<person name="Bourbeau M.P."/>
<person name="Wang X."/>
<person name="Yao G."/>
<person name="Tadesse S."/>
<person name="Rider J.T."/>
<person name="Yuan C.C."/>
<person name="Hong F.-T."/>
<person name="Lee M.R."/>
<person name="Zhang S."/>
<person name="Lofgren J.A."/>
<person name="Freeman D.J."/>
<person name="Yang S."/>
<person name="Li C."/>
<person name="Tominey E."/>
<person name="Huang X."/>
<person name="Hoffman D."/>
<person name="Yamane H.K."/>
<person name="Fotsch C."/>
<person name="Dominguez C."/>
<person name="Hungate R."/>
<person name="Zhang X."/>
</authorList>
<dbReference type="PubMed" id="20137943"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2010.01.067"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS)</scope>
<scope>PHOSPHORYLATION AT THR-198 AND SER-339</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="J. Med. Chem." volume="53" first="4615" last="4622">
<title>Design of selective, ATP-competitive inhibitors of Akt.</title>
<authorList>
<person name="Freeman-Cook K.D."/>
<person name="Autry C."/>
<person name="Borzillo G."/>
<person name="Gordon D."/>
<person name="Barbacci-Tobin E."/>
<person name="Bernardo V."/>
<person name="Briere D."/>
<person name="Clark T."/>
<person name="Corbett M."/>
<person name="Jakubczak J."/>
<person name="Kakar S."/>
<person name="Knauth E."/>
<person name="Lippa B."/>
<person name="Luzzio M.J."/>
<person name="Mansour M."/>
<person name="Martinelli G."/>
<person name="Marx M."/>
<person name="Nelson K."/>
<person name="Pandit J."/>
<person name="Rajamohan F."/>
<person name="Robinson S."/>
<person name="Subramanyam C."/>
<person name="Wei L."/>
<person name="Wythes M."/>
<person name="Morris J."/>
</authorList>
<dbReference type="PubMed" id="20481595"/>
<dbReference type="DOI" id="10.1021/jm1003842"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS)</scope>
<scope>PHOSPHORYLATION AT THR-198 AND SER-339</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="J. Mol. Biol." volume="403" first="66" last="77">
<title>Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions.</title>
<authorList>
<person name="Pflug A."/>
<person name="Rogozina J."/>
<person name="Lavogina D."/>
<person name="Enkvist E."/>
<person name="Uri A."/>
<person name="Engh R.A."/>
<person name="Bossemeyer D."/>
</authorList>
<dbReference type="PubMed" id="20732331"/>
<dbReference type="DOI" id="10.1016/j.jmb.2010.08.028"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH ADENOSINE ANALOG</scope>
<scope>PHOSPHORYLATION AT SER-11; THR-198 AND SER-339</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Biochem. J." volume="440" first="85" last="93">
<title>Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinase.</title>
<authorList>
<person name="Pflug A."/>
<person name="de Oliveira T.M."/>
<person name="Bossemeyer D."/>
<person name="Engh R.A."/>
</authorList>
<dbReference type="PubMed" id="21774789"/>
<dbReference type="DOI" id="10.1042/BJ20110592"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH AURORA KINASE INHIBITORS</scope>
<scope>PHOSPHORYLATION AT SER-11; THR-198 AND SER-339</scope>
<scope>MUTAGENESIS OF LYS-48; LEU-96; MET-121; VAL-124; GLN-182 AND THR-184</scope>
</reference>
<reference key="41">
<citation type="submission" date="2010-07" db="PDB data bank">
<title>Experimental active site mapping as a starting point to fragment-based lead discovery.</title>
<authorList>
<person name="Behnen J."/>
<person name="Koester H."/>
<person name="Ritschel T."/>
<person name="Neudert G."/>
<person name="Heine A."/>
<person name="Klebe G."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS)</scope>
<scope>PHOSPHORYLATION AT THR-198 AND SER-339</scope>
</reference>
<reference key="42">
<citation type="submission" date="2010-09" db="PDB data bank">
<title>Fragment based drug design on PKA.</title>
<authorList>
<person name="Koester H."/>
<person name="Craan T."/>
<person name="Brass S."/>
<person name="Heine A."/>
<person name="Klebe G."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS)</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-41; GLN-46 AND CYS-264</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2014" name="N. Engl. J. Med." volume="370" first="1019" last="1028">
<title>Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.</title>
<authorList>
<person name="Beuschlein F."/>
<person name="Fassnacht M."/>
<person name="Assie G."/>
<person name="Calebiro D."/>
<person name="Stratakis C.A."/>
<person name="Osswald A."/>
<person name="Ronchi C.L."/>
<person name="Wieland T."/>
<person name="Sbiera S."/>
<person name="Faucz F.R."/>
<person name="Schaak K."/>
<person name="Schmittfull A."/>
<person name="Schwarzmayr T."/>
<person name="Barreau O."/>
<person name="Vezzosi D."/>
<person name="Rizk-Rabin M."/>
<person name="Zabel U."/>
<person name="Szarek E."/>
<person name="Salpea P."/>
<person name="Forlino A."/>
<person name="Vetro A."/>
<person name="Zuffardi O."/>
<person name="Kisker C."/>
<person name="Diener S."/>
<person name="Meitinger T."/>
<person name="Lohse M.J."/>
<person name="Reincke M."/>
<person name="Bertherat J."/>
<person name="Strom T.M."/>
<person name="Allolio B."/>
</authorList>
<dbReference type="PubMed" id="24571724"/>
<dbReference type="DOI" id="10.1056/NEJMoa1310359"/>
</citation>
<scope>VARIANT PPNAD4 ARG-206</scope>
<scope>CHARACTERIZATION OF VARIANT PPNAD4 ARG-206</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2014" name="Science" volume="344" first="913" last="917">
<title>Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.</title>
<authorList>
<person name="Cao Y."/>
<person name="He M."/>
<person name="Gao Z."/>
<person name="Peng Y."/>
<person name="Li Y."/>
<person name="Li L."/>
<person name="Zhou W."/>
<person name="Li X."/>
<person name="Zhong X."/>
<person name="Lei Y."/>
<person name="Su T."/>
<person name="Wang H."/>
<person name="Jiang Y."/>
<person name="Yang L."/>
<person name="Wei W."/>
<person name="Yang X."/>
<person name="Jiang X."/>
<person name="Liu L."/>
<person name="He J."/>
<person name="Ye J."/>
<person name="Wei Q."/>
<person name="Li Y."/>
<person name="Wang W."/>
<person name="Wang J."/>
<person name="Ning G."/>
</authorList>
<dbReference type="PubMed" id="24700472"/>
<dbReference type="DOI" id="10.1126/science.1249480"/>
</citation>
<scope>VARIANT PPNAD4 ARG-206</scope>
<scope>CHARACTERIZATION OF VARIANT PPNAD4 ARG-206</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2014" name="Science" volume="344" first="917" last="920">
<title>Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.</title>
<authorList>
<person name="Sato Y."/>
<person name="Maekawa S."/>
<person name="Ishii R."/>
<person name="Sanada M."/>
<person name="Morikawa T."/>
<person name="Shiraishi Y."/>
<person name="Yoshida K."/>
<person name="Nagata Y."/>
<person name="Sato-Otsubo A."/>
<person name="Yoshizato T."/>
<person name="Suzuki H."/>
<person name="Shiozawa Y."/>
<person name="Kataoka K."/>
<person name="Kon A."/>
<person name="Aoki K."/>
<person name="Chiba K."/>
<person name="Tanaka H."/>
<person name="Kume H."/>
<person name="Miyano S."/>
<person name="Fukayama M."/>
<person name="Nureki O."/>
<person name="Homma Y."/>
<person name="Ogawa S."/>
</authorList>
<dbReference type="PubMed" id="24855271"/>
<dbReference type="DOI" id="10.1126/science.1252328"/>
</citation>
<scope>VARIANT PPNAD4 ARG-206</scope>
<scope>CHARACTERIZATION OF VARIANT PPNAD4 ARG-206</scope>
</reference>
<comment type="function">
<text evidence="16 17 18 20 22 23 26 27 29 32 33 34 36">Phosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis. Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA and VASP. RORA is activated by phosphorylation. Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts. Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP. Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated. RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+). PSMC5/RPT6 activation by phosphorylation stimulates proteasome. Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding. Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis. Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation. May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT). Phosphorylates APOBEC3G and AICDA. Isoform 2 phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490).</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="24 25 27 28 30 31">Allosterically activated by various compounds, including ATP. Activated by cAMP; the nucleotide acts as a dynamic and allosteric activator by coupling the two lobes of apo PKA, enhancing the enzyme dynamics synchronously and priming it for catalysis. Inhibited by H89 (N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide), spiroindoline, azole-based inhibitors, (3s)-amino-aminomethylbenzamide analogs, ARC-1032 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-carbamoylbutyl]hexanamide), ARC-1034 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]hexanamide), ARC-582, ARC-902 (Adc-6-aminohexanoic acid-(D-Arg)(6)-NH(2)), ARC-1012 ((2R)-6-amino-2-(6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}hexanamido)-N-(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)hexanamide) and ARC-1039 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-1-[(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)carbamoyl]ethyl]he xanamide).</text>
</comment>
<comment type="subunit">
<text evidence="10 15 18 26 29 31 32 35 36">A number of inactive tetrameric holoenzymes are produced by the combination of homo- or heterodimers of the different regulatory subunits associated with two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. The cAMP-dependent protein kinase catalytic subunit binds PJA2. Both isoforms 1 and 2 forms activate cAMP-sensitive PKAI and PKAII holoenzymes by interacting with regulatory subunit (R) of PKA, PRKAR1A/PKR1 and PRKAR2A/PKR2, respectively. Interacts with NFKB1, NFKB2 and NFKBIA in platelets; these interactions are disrupted by thrombin and collagen. Binds to ABL1 in spermatozoa and with CDC25B in oocytes. Interacts with APOBEC3G and AICDA. Interacts with RAB13; downstream effector of RAB13 involved in tight junction assembly. Found in a complex at least composed of MROH2B, PRKACA isoform 2 and TCP11 (By similarity). Interacts with MROH2B (By similarity). Isoform 2 interacts with TCP11 (By similarity). Interacts with HSF1 (PubMed:21085490).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-3834328">
<id>Q9GZX7</id>
<label>AICDA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-517035">
<id>Q9NQ31</id>
<label>AKIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-79934">
<id>P09917</id>
<label>ALOX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-717839">
<id>Q9HC16</id>
<label>APOBEC3G</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-8071125">
<id>P59215</id>
<label>Gnao1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-5323863">
<id>Q5S007</id>
<label>LRRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-476431">
<id>P10644</id>
<label>PRKAR1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-2805516">
<id>P31321</id>
<label>PRKAR1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-2930670">
<id>P31323</id>
<label>PRKAR2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476586"/>
<interactant intactId="EBI-6096160">
<id>P12369</id>
<label>Prkar2b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Mitochondrion</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="47">Membrane</location>
<topology evidence="47">Lipid-anchor</topology>
</subcellularLocation>
<text evidence="9 32">Translocates into the nucleus (monomeric catalytic subunit). The inactive holoenzyme is found in the cytoplasm. Distributed throughout the cytoplasm in meiotically incompetent oocytes. Associated to mitochondrion as meiotic competence is acquired. Aggregates around the germinal vesicles (GV) at the immature GV stage oocytes (By similarity). Colocalizes with HSF1 in nuclear stress bodies (nSBs) upon heat shock (PubMed:21085490).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="13">Cell projection</location>
<location evidence="13">cilium</location>
<location evidence="13">flagellum</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Cytoplasmic vesicle</location>
<location evidence="10">secretory vesicle</location>
<location evidence="10">acrosome</location>
</subcellularLocation>
<text evidence="10 13">Expressed in the midpiece region of the sperm flagellum (PubMed:10906071). Colocalizes with MROH2B and TCP11 on the acrosome and tail regions in round spermatids and spermatozoa regardless of the capacitation status of the sperm (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P17612-1</id>
<name>1</name>
<name>C-alpha-1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P17612-2</id>
<name>2</name>
<name>C-alpha-2</name>
<name>C-alpha-S</name>
<name>C(s)</name>
<sequence type="described" ref="VSP_004759"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13 36">Isoform 1 is ubiquitous. Isoform 2 is sperm-specific and is enriched in pachytene spermatocytes but is not detected in round spermatids.</text>
</comment>
<comment type="PTM">
<text evidence="9">Asn-3 is partially deaminated to Asp giving rise to 2 major isoelectric variants, called CB and CA respectively.</text>
</comment>
<comment type="PTM">
<text evidence="14 19 24 28 30 31 35 43">Autophosphorylated. Phosphorylation is enhanced by vitamin K(2). Phosphorylated on threonine and serine residues. Phosphorylation on Thr-198 is required for full activity.</text>
</comment>
<comment type="PTM">
<text evidence="9">Phosphorylated at Tyr-331 by activated receptor tyrosine kinases EGFR and PDGFR; this increases catalytic efficienncy.</text>
</comment>
<comment type="disease" evidence="37 38 39 40">
<disease id="DI-04115">
<name>Primary pigmented nodular adrenocortical disease 4</name>
<acronym>PPNAD4</acronym>
<description>A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes.</description>
<dbReference type="MIM" id="615830"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="47">Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. cAMP subfamily.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/prkaca/"/>
</comment>
<dbReference type="EC" id="2.7.11.11"/>
<dbReference type="EMBL" id="X07767">
<property type="protein sequence ID" value="CAA30597.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290147">
<property type="protein sequence ID" value="BAF82836.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ667173">
<property type="protein sequence ID" value="ABG25918.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471106">
<property type="protein sequence ID" value="EAW84399.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039846">
<property type="protein sequence ID" value="AAH39846.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC108259">
<property type="protein sequence ID" value="AAI08260.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF208004">
<property type="protein sequence ID" value="AAG35720.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF239744">
<property type="protein sequence ID" value="AAF76426.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF224718">
<property type="protein sequence ID" value="AAF75622.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12304.1">
<molecule id="P17612-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12305.1">
<molecule id="P17612-2"/>
</dbReference>
<dbReference type="PIR" id="S01404">
<property type="entry name" value="OKHU2C"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001291278.1">
<property type="nucleotide sequence ID" value="NM_001304349.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002721.1">
<molecule id="P17612-1"/>
<property type="nucleotide sequence ID" value="NM_002730.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_997401.1">
<molecule id="P17612-2"/>
<property type="nucleotide sequence ID" value="NM_207518.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.631630"/>
<dbReference type="PDB" id="2GU8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=15-351"/>
</dbReference>
<dbReference type="PDB" id="3AGL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=1-351"/>
</dbReference>
<dbReference type="PDB" id="3AGM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3AMA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3AMB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3L9L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1-351"/>
</dbReference>
<dbReference type="PDB" id="3L9M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1-351"/>
</dbReference>
<dbReference type="PDB" id="3L9N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3MVJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="A/B/E=1-351"/>
</dbReference>
<dbReference type="PDB" id="3NX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3OOG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3OVV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3OWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3OXT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3P0M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3POO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="3VQH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="4AE6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=16-351"/>
</dbReference>
<dbReference type="PDB" id="4AE9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=16-351"/>
</dbReference>
<dbReference type="PDB" id="4UJ1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="4UJ2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="4UJ9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="4UJA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="4UJB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="4WB5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="A=2-351"/>
</dbReference>
<dbReference type="PDB" id="4WB6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=2-351"/>
</dbReference>
<dbReference type="PDB" id="4WB7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=16-351"/>
</dbReference>
<dbReference type="PDB" id="4WB8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=16-351"/>
</dbReference>
<dbReference type="PDB" id="5BX6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="5BX7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=1-350"/>
</dbReference>
<dbReference type="PDB" id="5IZF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDB" id="5IZJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=1-351"/>
</dbReference>
<dbReference type="PDB" id="5J5X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-351"/>
</dbReference>
<dbReference type="PDBsum" id="2GU8"/>
<dbReference type="PDBsum" id="3AGL"/>
<dbReference type="PDBsum" id="3AGM"/>
<dbReference type="PDBsum" id="3AMA"/>
<dbReference type="PDBsum" id="3AMB"/>
<dbReference type="PDBsum" id="3L9L"/>
<dbReference type="PDBsum" id="3L9M"/>
<dbReference type="PDBsum" id="3L9N"/>
<dbReference type="PDBsum" id="3MVJ"/>
<dbReference type="PDBsum" id="3NX8"/>
<dbReference type="PDBsum" id="3OOG"/>
<dbReference type="PDBsum" id="3OVV"/>
<dbReference type="PDBsum" id="3OWP"/>
<dbReference type="PDBsum" id="3OXT"/>
<dbReference type="PDBsum" id="3P0M"/>
<dbReference type="PDBsum" id="3POO"/>
<dbReference type="PDBsum" id="3VQH"/>
<dbReference type="PDBsum" id="4AE6"/>
<dbReference type="PDBsum" id="4AE9"/>
<dbReference type="PDBsum" id="4UJ1"/>
<dbReference type="PDBsum" id="4UJ2"/>
<dbReference type="PDBsum" id="4UJ9"/>
<dbReference type="PDBsum" id="4UJA"/>
<dbReference type="PDBsum" id="4UJB"/>
<dbReference type="PDBsum" id="4WB5"/>
<dbReference type="PDBsum" id="4WB6"/>
<dbReference type="PDBsum" id="4WB7"/>
<dbReference type="PDBsum" id="4WB8"/>
<dbReference type="PDBsum" id="5BX6"/>
<dbReference type="PDBsum" id="5BX7"/>
<dbReference type="PDBsum" id="5IZF"/>
<dbReference type="PDBsum" id="5IZJ"/>
<dbReference type="PDBsum" id="5J5X"/>
<dbReference type="ProteinModelPortal" id="P17612"/>
<dbReference type="SMR" id="P17612"/>
<dbReference type="BioGrid" id="111553">
<property type="interactions" value="148"/>
</dbReference>
<dbReference type="CORUM" id="P17612"/>
<dbReference type="DIP" id="DIP-33878N"/>
<dbReference type="ELM" id="P17612"/>
<dbReference type="IntAct" id="P17612">
<property type="interactions" value="88"/>
</dbReference>
<dbReference type="MINT" id="MINT-95365"/>
<dbReference type="STRING" id="9606.ENSP00000309591"/>
<dbReference type="BindingDB" id="P17612"/>
<dbReference type="ChEMBL" id="CHEMBL4101"/>
<dbReference type="DrugBank" id="DB07107">
<property type="generic name" value="(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB06959">
<property type="generic name" value="(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07857">
<property type="generic name" value="(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07860">
<property type="generic name" value="(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08073">
<property type="generic name" value="(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB06977">
<property type="generic name" value="(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08568">
<property type="generic name" value="(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07858">
<property type="generic name" value="(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08756">
<property type="generic name" value="(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07855">
<property type="generic name" value="(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07876">
<property type="generic name" value="(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08070">
<property type="generic name" value="2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08113">
<property type="generic name" value="3-pyridin-4-yl-1H-indazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB07859">
<property type="generic name" value="4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07996">
<property type="generic name" value="5-(2-methylpiperazine-1-sulfonyl)isoquinoline"/>
</dbReference>
<dbReference type="DrugBank" id="DB07856">
<property type="generic name" value="6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB04098">
<property type="generic name" value="Balanol"/>
</dbReference>
<dbReference type="DrugBank" id="DB02611">
<property type="generic name" value="Balanol Analog 1"/>
</dbReference>
<dbReference type="DrugBank" id="DB01940">
<property type="generic name" value="Balanol Analog 2"/>
</dbReference>
<dbReference type="DrugBank" id="DB02155">
<property type="generic name" value="Balanol Analog 8"/>
</dbReference>
<dbReference type="DrugBank" id="DB08846">
<property type="generic name" value="Ellagic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB04707">
<property type="generic name" value="HYDROXYFASUDIL"/>
</dbReference>
<dbReference type="DrugBank" id="DB07947">
<property type="generic name" value="ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08231">
<property type="generic name" value="MYRISTIC ACID"/>
</dbReference>
<dbReference type="DrugBank" id="DB07995">
<property type="generic name" value="N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07997">
<property type="generic name" value="N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07854">
<property type="generic name" value="N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB01919">
<property type="generic name" value="Pentanal"/>
</dbReference>
<dbReference type="DrugBank" id="DB04522">
<property type="generic name" value="Phosphonoserine"/>
</dbReference>
<dbReference type="DrugBank" id="DB02482">
<property type="generic name" value="Phosphonothreonine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1476"/>
<dbReference type="iPTMnet" id="P17612"/>
<dbReference type="PhosphoSitePlus" id="P17612"/>
<dbReference type="SwissPalm" id="P17612"/>
<dbReference type="BioMuta" id="PRKACA"/>
<dbReference type="DMDM" id="125205"/>
<dbReference type="EPD" id="P17612"/>
<dbReference type="MaxQB" id="P17612"/>
<dbReference type="PaxDb" id="P17612"/>
<dbReference type="PeptideAtlas" id="P17612"/>
<dbReference type="PRIDE" id="P17612"/>
<dbReference type="DNASU" id="5566"/>
<dbReference type="Ensembl" id="ENST00000308677">
<molecule id="P17612-1"/>
<property type="protein sequence ID" value="ENSP00000309591"/>
<property type="gene ID" value="ENSG00000072062"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000589994">
<molecule id="P17612-2"/>
<property type="protein sequence ID" value="ENSP00000466651"/>
<property type="gene ID" value="ENSG00000072062"/>
</dbReference>
<dbReference type="GeneID" id="5566"/>
<dbReference type="KEGG" id="hsa:5566"/>
<dbReference type="UCSC" id="uc002myb.4">
<molecule id="P17612-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5566"/>
<dbReference type="DisGeNET" id="5566"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000072062.13"/>
<dbReference type="GeneCards" id="PRKACA"/>
<dbReference type="HGNC" id="HGNC:9380">
<property type="gene designation" value="PRKACA"/>
</dbReference>
<dbReference type="HPA" id="CAB010361"/>
<dbReference type="HPA" id="HPA071185"/>
<dbReference type="MalaCards" id="PRKACA"/>
<dbReference type="MIM" id="601639">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615830">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P17612"/>
<dbReference type="OpenTargets" id="ENSG00000072062"/>
<dbReference type="Orphanet" id="401920">
<property type="disease" value="Fibrolamellar hepatocellular carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33748"/>
<dbReference type="eggNOG" id="KOG0616">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPQQ">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00810000125385"/>
<dbReference type="HOGENOM" id="HOG000233033"/>
<dbReference type="HOVERGEN" id="HBG108317"/>
<dbReference type="InParanoid" id="P17612"/>
<dbReference type="KO" id="K04345"/>
<dbReference type="OMA" id="GQHFAMK"/>
<dbReference type="OrthoDB" id="EOG091G10O8"/>
<dbReference type="PhylomeDB" id="P17612"/>
<dbReference type="TreeFam" id="TF313399"/>
<dbReference type="BRENDA" id="2.7.11.11">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111931">
<property type="pathway name" value="PKA-mediated phosphorylation of CREB"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-163358">
<property type="pathway name" value="PKA-mediated phosphorylation of key metabolic factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-163560">
<property type="pathway name" value="Triglyceride catabolism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-163615">
<property type="pathway name" value="PKA activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-164378">
<property type="pathway name" value="PKA activation in glucagon signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180024">
<property type="pathway name" value="DARPP-32 events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2565942">
<property type="pathway name" value="Regulation of PLK1 Activity at G2/M Transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380259">
<property type="pathway name" value="Loss of Nlp from mitotic centrosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380270">
<property type="pathway name" value="Recruitment of mitotic centrosome proteins and complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380284">
<property type="pathway name" value="Loss of proteins required for interphase microtubule organization from the centrosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380320">
<property type="pathway name" value="Recruitment of NuMA to mitotic centrosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381676">
<property type="pathway name" value="Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-392517">
<property type="pathway name" value="Rap1 signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-422356">
<property type="pathway name" value="Regulation of insulin secretion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-432040">
<property type="pathway name" value="Vasopressin regulates renal water homeostasis via Aquaporins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-442720">
<property type="pathway name" value="CREB phosphorylation through the activation of Adenylate Cyclase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-512988">
<property type="pathway name" value="Interleukin-3, 5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578775">
<property type="pathway name" value="Ion homeostasis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5610780">
<property type="pathway name" value="Degradation of GLI1 by the proteasome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5610783">
<property type="pathway name" value="Degradation of GLI2 by the proteasome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5610785">
<property type="pathway name" value="GLI3 is processed to GLI3R by the proteasome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5610787">
<property type="pathway name" value="Hedgehog 'off' state"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5620912">
<property type="pathway name" value="Anchoring of the basal body to the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5687128">
<property type="pathway name" value="MAPK6/MAPK4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-70171">
<property type="pathway name" value="Glycolysis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853659">
<property type="pathway name" value="RET signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854518">
<property type="pathway name" value="AURKA Activation by TPX2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963896">
<property type="pathway name" value="HDL assembly"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9010642">
<property type="pathway name" value="ROBO receptors bind AKAP5"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983231">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="SABIO-RK" id="P17612"/>
<dbReference type="SignaLink" id="P17612"/>
<dbReference type="SIGNOR" id="P17612"/>
<dbReference type="ChiTaRS" id="PRKACA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P17612"/>
<dbReference type="GeneWiki" id="PRKACA"/>
<dbReference type="GenomeRNAi" id="5566"/>
<dbReference type="PRO" id="PR:P17612"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000072062"/>
<dbReference type="CleanEx" id="HS_PRKACA"/>
<dbReference type="ExpressionAtlas" id="P17612">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P17612">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0001669">
<property type="term" value="C:acrosomal vesicle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034704">
<property type="term" value="C:calcium channel complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005952">
<property type="term" value="C:cAMP-dependent protein kinase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097546">
<property type="term" value="C:ciliary base"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045171">
<property type="term" value="C:intercellular bridge"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0031514">
<property type="term" value="C:motile cilium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031588">
<property type="term" value="C:nucleotide-activated protein kinase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044853">
<property type="term" value="C:plasma membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097225">
<property type="term" value="C:sperm midpiece"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004691">
<property type="term" value="F:cAMP-dependent protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034237">
<property type="term" value="F:protein kinase A regulatory subunit binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004712">
<property type="term" value="F:protein serine/threonine/tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034199">
<property type="term" value="P:activation of protein kinase A activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035584">
<property type="term" value="P:calcium-mediated signaling using intracellular calcium source"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0086064">
<property type="term" value="P:cell communication by electrical coupling involved in cardiac conduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071872">
<property type="term" value="P:cellular response to epinephrine stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071377">
<property type="term" value="P:cellular response to glucagon stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071333">
<property type="term" value="P:cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034605">
<property type="term" value="P:cellular response to heat"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097711">
<property type="term" value="P:ciliary basal body-plasma membrane docking"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034380">
<property type="term" value="P:high-density lipoprotein particle assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000810">
<property type="term" value="P:regulation of bicellular tight junction assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903779">
<property type="term" value="P:regulation of cardiac conduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0055117">
<property type="term" value="P:regulation of cardiac muscle contraction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010881">
<property type="term" value="P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051480">
<property type="term" value="P:regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010389">
<property type="term" value="P:regulation of G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002027">
<property type="term" value="P:regulation of heart rate"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016241">
<property type="term" value="P:regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045667">
<property type="term" value="P:regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061136">
<property type="term" value="P:regulation of proteasomal protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043393">
<property type="term" value="P:regulation of protein binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060314">
<property type="term" value="P:regulation of ryanodine-sensitive calcium-release channel activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003091">
<property type="term" value="P:renal water homeostasis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048240">
<property type="term" value="P:sperm capacitation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR000961">
<property type="entry name" value="AGC-kinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00133">
<property type="entry name" value="S_TK_X"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51285">
<property type="entry name" value="AGC_KINASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0114">cAMP</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0969">Cilium</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-1062">Cushing syndrome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0282">Flagellum</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0519">Myristate</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="initiator methionine" description="Removed" evidence="41 42">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="cAMP-dependent protein kinase catalytic subunit alpha" id="PRO_0000086052">
<location>
<begin position="2"/>
<end position="351"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="11">
<location>
<begin position="44"/>
<end position="298"/>
</location>
</feature>
<feature type="domain" description="AGC-kinase C-terminal">
<location>
<begin position="299"/>
<end position="351"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="50"/>
<end position="58"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="11">
<location>
<begin position="122"/>
<end position="128"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="11">
<location>
<begin position="169"/>
<end position="172"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="11 12">
<location>
<position position="167"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="11">
<location>
<position position="73"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="9">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="10">
<location>
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="49"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="140"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="196"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PDPK1" evidence="14 19 28 30 31 35 43">
<location>
<position position="198"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 8 19 28 30 31 35 43">
<location>
<position position="339"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="N-myristoyl glycine" evidence="41 42">
<location>
<position position="2"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004759" evidence="44 45 46">
<original>MGNAAAAKKGSEQES</original>
<variation>MASNSSD</variation>
<location>
<begin position="1"/>
<end position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56029020." id="VAR_040591" evidence="21">
<original>L</original>
<variation>V</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56085217." id="VAR_040592" evidence="21">
<original>R</original>
<variation>Q</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In PPNAD4; somatic mutation; the mutation results in cAMP-independent basal protein kinase activity and constitutive activation of protein kinase A; dbSNP:rs386352352." id="VAR_071707" evidence="37 38 39 40">
<original>L</original>
<variation>R</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35635531." id="VAR_040593" evidence="21">
<original>S</original>
<variation>C</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced basal kinase activity; when associated with Q-96, L-121, A-124, K-182 and A-184." evidence="35">
<original>K</original>
<variation>R</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced basal kinase activity; when associated with R-48, L-121, A-124, K-182 and A-184." evidence="35">
<original>L</original>
<variation>Q</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced basal kinase activity; when associated with R-48, Q-96, A-124, K-182 and A-184." evidence="35">
<original>M</original>
<variation>L</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, K-182 and A-184." evidence="35">
<original>V</original>
<variation>A</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, A-124 and A-184." evidence="35">
<original>Q</original>
<variation>K</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, A-124 and K-182." evidence="35">
<original>T</original>
<variation>A</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="mutagenesis site" description="No phosphorylation." evidence="14">
<original>R</original>
<variation>A</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="mutagenesis site" description="No phosphorylation." evidence="14">
<original>G</original>
<variation>A</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="No phosphorylation." evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of allosteric regulation." evidence="25">
<original>Y</original>
<variation>A</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3"/>
<end position="6"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="16"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="41"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="44"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="57"/>
<end position="63"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="69"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="77"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="86"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="107"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="114"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="129"/>
<end position="136"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="141"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="170"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="186"/>
<end position="188"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="208"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="212"/>
<end position="214"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="219"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="244"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="264"/>
<end position="273"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="286"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="290"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="303"/>
<end position="307"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="345"/>
<end position="350"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3AMA"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UJ2"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WB8"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IZF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IZJ"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P05132"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10906071"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12372837"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15096524"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15642694"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15905176"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16387847"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16765046"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17333334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17565987"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17693412"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17909264"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18178622"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18836454"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19949837"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20137943"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20356841"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20481595"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20732331"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21085490"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21423175"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21514275"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21774789"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21812984"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24571724"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24700472"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24747643"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24855271"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25255805"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25807930"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source ref="41"/>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10841548"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10906071"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10982398"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305"/>
<sequence length="351" mass="40590" checksum="BF6D3ECD2614E5AB" modified="2007-01-23" version="2">
MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVML
VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV
MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY
IQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF
ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT
TDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>